Select Medical Holdings Corporation (SEM)
NYSE: SEM · Real-Time Price · USD
16.56
+0.01 (0.06%)
Jun 23, 2026, 4:00 PM EDT - Market closed
Select Medical Holdings Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 203.58 | 214.53 | 296.7 | 299.73 | 198.03 | 499.95 |
Depreciation & Amortization | 143.16 | 140.3 | 203.89 | 208.74 | 205.83 | 202.65 |
Stock-Based Compensation | 17.45 | 16.7 | 100.67 | 43.81 | 37.76 | 30.94 |
Other Adjustments | 40.61 | 34.61 | -28.27 | -29.72 | 2.76 | -2.33 |
Change in Receivables | -42.47 | -45.19 | -95.85 | 1.16 | -52.18 | 23.1 |
Changes in Accounts Payable | 45.45 | -0.85 | -16.79 | -6.41 | -48.04 | 53.39 |
Changes in Accrued Expenses | -11.22 | -5.24 | 26.49 | 84.1 | 12.85 | -73.16 |
Changes in Other Operating Activities | -3.76 | -8.4 | 31.01 | -19.34 | -72.17 | -333.31 |
Operating Cash Flow | 387.78 | 346.47 | 517.86 | 582.06 | 284.83 | 401.23 |
Operating Cash Flow Growth | - | -33.10% | -11.03% | 104.36% | -29.01% | -60.97% |
Capital Expenditures | -235.78 | -229.23 | -222.18 | -229.2 | -190.37 | -180.54 |
Sale of Property, Plant & Equipment | 25.58 | 23.39 | 4.26 | 0.16 | 8.34 | 26.82 |
Purchases of Investments | - | -1.46 | - | -9.87 | -17.32 | -20.97 |
Payments for Business Acquisitions | -9.17 | -9.2 | -13.1 | -29.57 | -26.99 | -81.91 |
Investing Cash Flow | -220.83 | -216.49 | -231.01 | -268.48 | -226.34 | -256.59 |
Short-Term Debt Issued | 1,135 | 1,290 | 1,240 | 905 | 1,120 | 160 |
Short-Term Debt Repaid | -1,190 | -1,295 | -1,415 | -1,070 | -835 | - |
Net Short-Term Debt Issued (Repaid) | -55 | -5 | -175 | -165 | 285 | 160 |
Long-Term Debt Issued | 104.57 | 101.22 | 3,082 | 2,124 | 25.67 | 33.01 |
Long-Term Debt Repaid | -47 | -44.83 | -3,396 | -2,161 | -35.59 | -39.67 |
Net Long-Term Debt Issued (Repaid) | 57.57 | 56.39 | -313.99 | -37.27 | -9.93 | -6.66 |
Issuance of Common Stock | - | - | 511.2 | - | - | - |
Repurchase of Common Stock | -88.69 | -100.08 | -37.91 | -12.76 | -195.53 | -79.48 |
Net Common Stock Issued (Repurchased) | -88.69 | -100.08 | 473.29 | -12.76 | -195.53 | -79.48 |
Common Dividends Paid | -31.13 | -31.44 | -64.62 | -63.9 | -64.59 | -50.6 |
Other Financing Activities | -77.24 | -83.03 | -230.85 | -48.55 | -49.85 | -670.65 |
Financing Cash Flow | -240.98 | -163.15 | -311.17 | -327.48 | -34.89 | -647.39 |
Net Cash Flow | -27.53 | -33.17 | -24.31 | -13.9 | 23.6 | -502.75 |
Free Cash Flow | 152 | 117.24 | 295.69 | 352.86 | 94.45 | 220.69 |
Free Cash Flow Growth | 29.65% | -60.35% | -16.20% | 273.58% | -57.20% | -74.97% |
FCF Margin | 2.75% | 2.15% | 5.70% | 7.31% | 2.05% | 3.56% |
Free Cash Flow Per Share | 1.25 | 0.96 | 2.37 | 2.87 | 0.76 | 1.64 |
Levered Free Cash Flow | 73.96 | 94.19 | -252.52 | 79.11 | 342.16 | 224.6 |
Unlevered Free Cash Flow | 191.16 | 161 | 221.99 | 249.17 | -15.79 | 235.71 |